Evaxion Biotech A/S ( EVAX) - Stock Earnings
EVAX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 20, 2026, midnight | — / — | — | — / — | — |
EVAX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -4.8 million USD | 37000 USD |
| 2025Q3 | 4.6 million USD | 7.5 million USD |
| 2025Q4 | -5.9 million USD | 22040 USD |
EVAX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -22.1 million USD | 73000 USD |
| 2024 | -10.6 million USD | 3.3 million USD |
| 2025 | -7.7 million USD | 7.5 million USD |
| 2026 Est. | — | — |
EVAX
Price: $2.96
52 week price:
Earnings Per Share: -1.00 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 302177
Market Capitalization: 21.5 million